1. Home
  2. RFL vs RAND Comparison

RFL vs RAND Comparison

Compare RFL & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • RAND
  • Stock Information
  • Founded
  • RFL 2017
  • RAND 1969
  • Country
  • RFL United States
  • RAND United States
  • Employees
  • RFL N/A
  • RAND N/A
  • Industry
  • RFL Real Estate
  • RAND Finance: Consumer Services
  • Sector
  • RFL Finance
  • RAND Finance
  • Exchange
  • RFL Nasdaq
  • RAND Nasdaq
  • Market Cap
  • RFL 55.3M
  • RAND 47.5M
  • IPO Year
  • RFL N/A
  • RAND N/A
  • Fundamental
  • Price
  • RFL $1.92
  • RAND $17.06
  • Analyst Decision
  • RFL
  • RAND
  • Analyst Count
  • RFL 0
  • RAND 0
  • Target Price
  • RFL N/A
  • RAND N/A
  • AVG Volume (30 Days)
  • RFL 27.8K
  • RAND 12.6K
  • Earning Date
  • RFL 12-27-2024
  • RAND 11-06-2024
  • Dividend Yield
  • RFL N/A
  • RAND 29.25%
  • EPS Growth
  • RFL N/A
  • RAND 123.39
  • EPS
  • RFL N/A
  • RAND 4.98
  • Revenue
  • RFL $697,000.00
  • RAND $8,351,941.00
  • Revenue This Year
  • RFL N/A
  • RAND N/A
  • Revenue Next Year
  • RFL N/A
  • RAND N/A
  • P/E Ratio
  • RFL N/A
  • RAND $3.58
  • Revenue Growth
  • RFL 151.62
  • RAND 16.96
  • 52 Week Low
  • RFL $1.29
  • RAND $12.81
  • 52 Week High
  • RFL $2.50
  • RAND $24.10
  • Technical
  • Relative Strength Index (RSI)
  • RFL 53.58
  • RAND 42.96
  • Support Level
  • RFL $1.71
  • RAND $18.67
  • Resistance Level
  • RFL $1.92
  • RAND $24.10
  • Average True Range (ATR)
  • RFL 0.10
  • RAND 1.34
  • MACD
  • RFL -0.00
  • RAND -0.26
  • Stochastic Oscillator
  • RFL 84.00
  • RAND 9.63

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About RAND Rand Capital Corporation

Rand Capital Corp is a closed-end, diversified management company. The firm's investment objectives is to maximize the total return to the shareholders with current income combined with capital appreciation. Some of its portfolios include lumious, and GiveGab among others.

Share on Social Networks: